CN Bio Innovations announces LiverChip research study with leading pharmaceutical company

Welwyn Garden City, UK, 27th May 2015: CN Bio Innovations, an expert in developing human organ-on-a-chip platforms to test and develop therapeutics for liver diseases and infection, is pleased to announce the commencement of a research study with a fourth pharmaceutical company.

The program will take advantage of CN Bio’s human liver-on-a-chip platform, LiverChip, to study targets implicated in liver disease.

filed under: Business